Skip to main content
main-content
Top

Hint

Swipe to navigate through the chapters of this book

2017 | OriginalPaper | Chapter

15. Pharmaceutical Applications

Authors : Mohab Anis, Ghada AlTaher, Wesam Sarhan, Mona Elsemary

Published in: Nanovate

Publisher: Springer International Publishing

share
SHARE

Abstract

A large number of already existing drugs suffer from poor water solubility, burst release and unfavorable side effects due to un-targeted delivery. Implantation of nanotechnology in the drug industry allows overcoming these problems and introducing drugs with enhanced water solubility, sustained release and targeted delivery to the diseased site. Moreover, nanotechnology allows reformulation of several hundred billion dollars of unused drugs instead of spending billions of dollars in formulating new drugs. Currently, several nano-based drug formulations have made their way into the market. Science push, observed side effects of the original product and developing better formulations are among the major drivers behind developing nano-based drugs. Meanwhile, safety concerns, regulatory approvals and required expertise and infrastructure are among the major barriers against the introduction of new nano-based drug formulations.
Literature
1.
go back to reference Cientifica (2012) Nanotechnology for drug delivery: global market for NanoCarriers. Author, London Cientifica (2012) Nanotechnology for drug delivery: global market for NanoCarriers. Author, London
2.
go back to reference Cientifica (2007) The nanotech revolution in drug delivery. Author, London Cientifica (2007) The nanotech revolution in drug delivery. Author, London
3.
go back to reference Junghanns JUA, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3:295 Junghanns JUA, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3:295
4.
go back to reference Von der Schulenburg F, Vandoros S, Kanavos P (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Econ Rev 1:1–8 CrossRef Von der Schulenburg F, Vandoros S, Kanavos P (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Econ Rev 1:1–8 CrossRef
5.
go back to reference De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133 CrossRef De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133 CrossRef
6.
go back to reference Kunde DS (2015) Biopharmaceutical classification system: a brief account. Int J Res Meth 1(1):20–46 MathSciNet Kunde DS (2015) Biopharmaceutical classification system: a brief account. Int J Res Meth 1(1):20–46 MathSciNet
7.
go back to reference (2014) Transparency market research. Transdermal drug delivery market—global industry analysis, size, share, growth, trends and forecast. Transparency market research, New York (2014) Transparency market research. Transdermal drug delivery market—global industry analysis, size, share, growth, trends and forecast. Transparency market research, New York
9.
go back to reference Business wire (2005) Esprit pharma acquires exclusive North American rights to ESTRASORB(R) topical emulsion; sees growing pre-eminence in women’s healthcare. ESPRIT PHARMA, North America Business wire (2005) Esprit pharma acquires exclusive North American rights to ESTRASORB(R) topical emulsion; sees growing pre-eminence in women’s healthcare. ESPRIT PHARMA, North America
10.
go back to reference ETC group (2006) Nano-drug’s dirty little secret. Author, London ETC group (2006) Nano-drug’s dirty little secret. Author, London
Metadata
Title
Pharmaceutical Applications
Authors
Mohab Anis
Ghada AlTaher
Wesam Sarhan
Mona Elsemary
Copyright Year
2017
DOI
https://doi.org/10.1007/978-3-319-44863-3_15